null溶血性贫血
Hemolytic Anemia溶血性贫血
Hemolytic Anemia华山医院血液科
陈勤奋HEMOLYTIC ANEMIA
(reduced RBC life span) HEMOLYTIC ANEMIA
(reduced RBC life span) Anemia of increased destruction
Normochromic, normochromic anemia
Shortened RBC survival
Reticulocytosis--Response to increased RBC destruction
Increased indirect bilirubin
Increased LDHMechanisms and CausesMechanisms and CausesINTRACORPUSCULAR HEMOLYSIS
Membrane Abnormalities
Metabolic Abnormalities
Hemoglobinopathies
EXTRACORPUSCULAR HEMOLYSIS
Nonimmune
ImmuneMembrane DefectsMembrane DefectsMicroskeletal defects
Hereditary spherocytosis
Increased sensitivity to complement
Paroxysmal nocturnal hemoglobinuriaEnzymopathiesEnzymopathiesGlucose 6-Phosphate Dehydrogenase Deficiency
Pyruvate Kinase DeficiencyHemoglobinopathiesHemoglobinopathiesHemoglobinopathy
ThalassemiaExtracorpuscular Hemolysis
NonimmuneExtracorpuscular Hemolysis
NonimmuneInfectious
Chemical
Thermal
OsmoticExtracorpuscular Hemolysis
ImmuneExtracorpuscular Hemolysis
ImmuneAll require antigen-antibody reactions
Types of reactions dependent on:
Class of Antibody
Number & Spacing of antigenic sites on cell
Availability of complement
Environmental Temperature
Functional status of reticuloendothelial system
Manifestations
Intravascular hemolysis
Extravascular hemolysisExtracorpuscular Hemolysis
ImmuneExtracorpuscular Hemolysis
ImmuneAntibodies combine with RBC, & either
Activate complement cascade, &/or
Opsonize RBC for immune system
If 1, if all of complement cascade is fixed to red cell, intravascular cell lysis occurs
If 2, &/or if complement is only partially fixed, macrophages recognize Fc receptor of Ig &/or C3b of complement & phagocytize RBC, causing extravascular RBC destructionClassificationClassificationIntravascular
Extravascularclinical featuresclinical featureschronic
pallor 、 jaundice 、 splenomegaly
cholelithiasis
aplastic crisis
acute
algor、hyperpyrexia、sore waist
hemoglobinuria
jaundice、anaemialaboratory examinationlaboratory examinationIncreased RBC destruction
Reduced RBC life span
Indirect hyperbilirubinemia
Erythroid hyperplasia
Reticulocytosis
Erythroblasts, anisopoikilocytosis, spherocytes in blood smear
Erythroid hyperplasia in bone marrow
nulldiagnosis and differential diagnosisdiagnosis and differential diagnosishemolysis or not?
type of hemolysis
another anemia?
another jaundice with anemia?
another jaundice without anemia?TreatmentTreatmentRemove the causes
Immunosupressive drug
Washed RBC transfusion
Splenectomy
Symptomatic treatmentHereditary SpherocytosisHereditary SpherocytosisDefective or absent spectrin molecule
Leads to loss of RBC membrane, leading to spherocytosis
Decreased deformability of cell
Increased osmotic fragility
Extravascular hemolysis in spleenHereditary SpherocytosisHereditary SpherocytosisPathophysiology--RBC membrane protein defects (spectrin deficiency) resulting cytoskeleton instability
Familly history
Clinical features—splenomegalyHereditary SpherocytosisHereditary SpherocytosisLaboratory features - hemolytic anemia - blood smear-microspherocytes - abnormal osmotic fragility test - positive autohemolysis test - prevention of increased autohemolysis by including glucose in incubation medium
Treatment--splenectomyHereditary SpherocytosisHereditary SpherocytosisHereditary Spherocytosis
Osmotic FragilityHereditary Spherocytosis
Osmotic FragilityParoxysmal Nocturnal Hemoglobinuria (PNH)Paroxysmal Nocturnal Hemoglobinuria (PNH)PNH is an acquired chronic hemolytic anemia which arises from a somatic mutation in a hematopoietic stem cell. Most hematopoitic cell lines may be affected by the intrinsic membrane defect. This defect renders the red cells highly susceptible to complement mediated lysis resulting in the characteristic hemolysis.Paroxysmal Nocturnal Hemoglobinuria (PNH)Paroxysmal Nocturnal Hemoglobinuria (PNH)Pathogenesis - an acquired clonal disease, arising from a somatic mutation in a single abnormal stem cell - glycosyl-phosphatidyl- inositol (GPI) anchor abnormality - deficiency of the GPI anchored membrane proteins(CD55 and CD59) - red cells are more sensitive to the lytic effect of complement - intravascular hemolysis urine aliquot of PNHurine aliquot of PNHclinical manifestationclinical manifestationpancytopenia
passage of dark brown urine in the morning
venous thrombosis(Budd-Chiari Syndrome)Laboratory featuresLaboratory featuresPancytopenia
Chronic urinary iron loss
Serum iron concentration decreased
Hemoglobinuria
Hemosiderinuria
Positive Ham’s test (acid hemolysis test), sugar-water test
Specific immunophenotype of blood cells(CD59, CD55) AttentionAttentionAA-PNH syndrome
AA→PNH
PNH→AA
PNH with AA
AA with PNHTreatmentTreatmentavoid causes
washed RBC transfusion
iron therapy
allogenic bone marrow transplantationG-6-PD DeficiencyG-6-PD Deficiencyacute hemolytic anemia
congenital nonspherocytic hemolytic anemia
neonatal hyperbilirubinemia (kernicterus)
favismnullLevel needed for protection vs ordinary oxidative stressAutoimmune HemolysisAutoimmune HemolysisDue to formation of autoantibodies that attack patient’s own RBC’s
Type characterized by ability of autoantibodies to fix complement & site of RBC destruction
Often associated with either lymphoproliferative disease or collagen vascular diseaseAutoimmune Hemolytic AnemiaAutoimmune Hemolytic Anemiawarm-reactive antibodies
primary
secondary
cold-reactive antibodies
cold agglutinin syndrome
paroxysmal cold hemoglubinuriaAutoimmune hematolysis
Warm TypeAutoimmune hematolysis
Warm TypeIgG+C3
IgG
C3Autoimmune hematolysis
Warm TypeAutoimmune hematolysis
Warm TypeUsually IgG antibodies
Fix complement only to level of C3,if at all
Immunoglobulin binding occurs at all temps
Fc receptors/C3b recognized by macrophages
Hemolysis primarily extravascular
70% associated with other illnesses
Responsive to steroids/splenectomyClinical manifestationClinical manifestationanemia、jaundice、splenohepatomegalia
ITP+AIHA=Evens syndromeLaboratory examinationLaboratory examinationBlood:anemia;Ret;erythroblasts, anisopoikilocytosis
Bone marrow:erythroid hyperplasia
Coombs TestCoombs Test - DirectCoombs Test - DirectLooks for immunoglobulin &/or complement of surface of red blood cell (normally neither found on RBC surface)
Coombs reagent - combination of anti-human immunoglobulin & anti-human complement
Mixed with patient’s red cells; if immunoglobulin or complement are on surface, Coombs reagent will link cells together and cause agglutination of RBCsCoombs Test - IndirectCoombs Test - IndirectLooks for anti-red blood cell antibodies in the patient’s serum, using a panel of red cells with known surface antigens
Combine patient’s serum with cells from a panel of RBC’s with known antigens
Add Coombs’ reagent to this mixture
If anti-RBC antigens are in serum, agglutination occursDiagnosisDiagnosisTreatmentTreatmentSteroids
Splenectomy
Immunosupressive agents
Transfusion
Autoimmune hematolysis
Cold TypeAutoimmune hematolysis
Cold TypeMost commonly IgM mediated
Antibodies bind best at 30º or lower
Fix entire complement cascade
Leads to formation of membrane attack complex, which leads to RBC lysis in vasculature
Typically only complement found on cells
90% associated with other illnesses
Poorly responsive to steroids, splenectomy; responsive to plasmapheresisHemolytic anemia
SummaryHemolytic anemia
SummaryMyriad causes of increased RBC destruction
Marrow function usually normal
Often requires extra folic acid to maintain hematopoiesis
Anything that turns off the bone marrow can result in acute, life-threatening anemia